Aurélie Dumont

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

Virginie Maire, Fariba Némati, Marion Richardson et al. · Cancer Research · 2012 · 193 citations · Full text

Medicine, Oncology, Pharmacology +17

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Virginie Maire, Céline Baldeyron, Marion Richardson et al. · PLoS ONE · 2013 · 169 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells

Florence Sancier, Aurélie Dumont, Audrey Sirvent et al. · PLoS ONE · 2011 · 40 citations · Full text

Medicine, Cell Biology, Oncology +17

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer

Émilie Le Rhun, Nicolas Bertrand, Aurélie Dumont et al. · European Journal of Cancer · 2017 · 40 citations · Full text

Medicine, Genetics, Oncology +17

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard, Michael Lush, Jonathan Beesley et al. · Nature Communications · 2021 · 39 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17